Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway

Inhibition of microglia activation may provide therapeutic treatment for many neurodegenerative diseases. Astragaloside IV (ASI) with anti-inflammatory properties has been tested as a therapeutic drug in clinical trials of China. However, the mechanism of ASI inhibiting neuroinflammation is unknown....

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hong-Shuai, Shi, Hai-Lian, Huang, Fei, Peterson, Karin E., Wu, Hui, Lan, Yun-Yi, Zhang, Bei-Bei, He, Yi-Xin, Woods, Tyson, Du, Min, Wu, Xiao-Jun, Wang, Zheng-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707476/
https://www.ncbi.nlm.nih.gov/pubmed/26750705
http://dx.doi.org/10.1038/srep19137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707476/
https://www.ncbi.nlm.nih.gov/pubmed/26750705
http://dx.doi.org/10.1038/srep19137

Ejemplares similares